ArticleNeuromolecular medicine2026
Evidence of 11β-hydroxysteroid Dehydrogenase Type 2 Protein Expression and Enzymatic Activity in the Adult Rat Brain.
Article in Neuromolecular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Intracellular glucocorticoid metabolism plays a critical role in shaping glucocorticoid receptor signaling in the brain. 11β-hydroxysteroid dehydrogenase type 2 (HSD11B2) catalyzes the NAD+-dependent oxidation of active glucocorticoids to inactive 11-keto forms, yet its expression and functional capacity in the adult brain are generally considered negligible, except for discrete brainstem nuclei. Here, we examined HSD11B2 expression in the adult rat brain at the mRNA and protein levels using quantitative real-time PCR, Western blotting, and immunohistochemistry. To assess catalytic function, HSD11B2 was immunoprecipitated from hippocampal lysates and assayed in vitro in the presence of NAD+, using cortisol as a substrate. Hsd11b2 mRNA and HSD11B2 protein were detected across all brain regions examined. Immunohistochemistry indicated predominant HSD11B2 immunoreactivity in hippocampal neurons. Both hippocampal homogenates and HSD11B2 immunoprecipitates displayed NAD+-dependent glucocorticoid dehydrogenase activity, consistent with enzymatic functionality. Collectively, these findings provide molecular and functional evidence for HSD11B2 expression and activity in the adult rat brain and motivate further studies to define its cellular localization and to clarify how local glucocorticoid inactivation influences hippocampal signaling and physiology.
Indexed as
Identifiers
42234068What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.